Home
Home

Affymax

1 Biotech With Room to Run (video)

1 Biotech With Room to Run (video)
Motley Fool

Affymax Poised To Take On Amgen?

Affymax Poised To Take On Amgen?
Seeking Alpha

Affymax's Anemia Drug Will Create Added Competition For Amgen

Affymax's Anemia Drug Will Create Added Competition For Amgen
Seeking Alpha
Submitted by admin on Sat, 03/31/2012 - 11:55

2-Star Stocks Poised to Plunge: Affymax?

2-Star Stocks Poised to Plunge: Affymax?
Motley Fool

FDA OKs New Anemia Med That Challenges Amgen

FDA OKs New Anemia Med That Challenges Amgen
Pharmalot

Will the FDA Approve Affymax's Peginesatide?

Will the FDA Approve Affymax's Peginesatide?
Motley Fool

Affymax rises after analyst sets 'Outperform' rating, ahead of FDA ruling on anemia drug

Affymax rises after analyst sets 'Outperform' rating, ahead of FDA ruling on anemia drug
Yahoo/AP

Affymax rises on analyst view of anemia drug

Affymax rises on analyst view of anemia drug
Yahoo/AP

Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March

Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March
Minyanville

The 9 Biotechs With The Highest Growth Expectations

The 9 Biotechs With The Highest Growth Expectations
Seeking Alpha